Päivi Östling

Päivi Östling has since 2011 been working on precision medicine in solid tumors first in prostate cancer and now also in renal and bladder cancer. This work has been part of a team science effort linked to the “Grand Challenge” on Individualized Systems Medicine, initially focused on leukemia but now including also solid tumors. This work was initiated at the Olli Kallioniemi research group, at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki and has now extended to the Science for Life Laboratory (SciLifeLab), Department of Oncology and Pathology, Karolinska Institutet, Sweden. Päivi currently operates as the co-PI of the Kallioniemi research group at SciLifeLab with specific focus on developing the next generation precision cancer medicine.